Articles

Verastem Articles

October 6, 2020BioSpaceNews

Verastem Oncology Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Oct 06, 2020

Verastem, Inc., a biopharmaceutical company committed to advancing new medicines for patients battlin... See more »
September 30, 2020BioSpaceNews

Secura Bio Completes Acquisition of Global Rights to Oncology Drug Copiktra

Secura Bio, Inc. (SBI) - ( www.securabio.com ), an integrated pharmaceutical company dedicated to the... See more »
September 16, 2020MarketScreenerNews

Oncology Announces Presentation of Updated Phase 1/2 FRAME Study Data at the 2nd Annual RAS-Targeted Drug Development Summit

(marketscreener.com) Preliminary Data on VS-6766 and Defactinib Combination Continues to Show Encoura... See more »
August 11, 2020Boston CitybizlistNews

Why Verastem Stock Jumped Briefly This Morning

August 11, 2020Pharamceutical TechnologyNews

Verastem to divest Copiktra rights to Secura Bio for up to $381m

Biopharmaceutical company Verastem has signed a definitive agreement to divest the global commercial ... See more »
August 10, 2020Endpoints NewsNews

The duvelisib hot potato is tossed to a new owner as Verastem looks to reorganize around the pipeline

When Infinity put up duvelisib for a no-money-down instant deal, the biotech was looking for a quick ... See more »
August 10, 2020BioSpaceNews

Verastem Oncology Reports Second Quarter 2020 Financial Results and Highlights Recent Company Progress

Announced Path Forward for VS-6766 and Defactinib Combination Following Meeting with FDA Phase 2 Regi... See more »
July 15, 2020Boston CitybizlistNews

A Growth Story In The Biotechnology Sector

July 5, 2020BioSpaceNews

Verastem Oncology Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - July 06, 2020

Verastem, Inc., a biopharmaceutical company committed to developing and commercializing new medicines... See more »
May 9, 2020centralchartsPress Release

Verastem, Inc. - VSTM Stock Chart Technical Analysis for 05-08-2020

News videos - Verastem, Inc. - VSTM Stock Chart Technical Analysis for 05-08-2020 - Published on 05/0... See more »
May 7, 2020Business WirePress Release

Verastem Oncology Reports First Quarter 2020 Financial Results and Highlights Recent Company Progress

BOSTON--(BUSINESS WIRE)--Verastem, Inc. (Nasdaq:VSTM) (also known as Verastem Oncology), a biopharmac... See more »
April 20, 2020centralchartsPress Release

Verastem, Inc. - VSTM Stock Chart Technical Analysis for 04-20-2020

News videos - Verastem, Inc. - VSTM Stock Chart Technical Analysis for 04-20-2020 - Published on 04/2... See more »
April 9, 2020GlobeNewswirePress Release

Fields Kupka & Shukurov LLP Is Investigating Verastem, Inc. for Potential Breach of Fiduciary Duty Claims.

NEW YORK, April 09, 2020 (GLOBE NEWSWIRE) -- Fields Kupka & Shukurov LLP is investigating potential b... See more »
December 7, 2019centralchartsPress Release

Verastem Oncology Presents Phase 2 PRIMO Study Data Evaluating Duvelisib in Relapsed or Refractory Peripheral T-Cell Lymphoma at the American Society of Hematology 2019 Annual Meeting

Verastem, Inc. (Nasdaq:VSTM) (Verastem Oncology or the Company), a biopharmaceutical company focused ... See more »
November 25, 2019Business WirePress Release

Verastem Oncology Announces Submission of a Marketing Authorization Application to the European Medicines Agency for COPIKTRA® (duvelisib)

BOSTON--(BUSINESS WIRE)--Verastem, Inc. (Nasdaq:VSTM) (Verastem Oncology or the Company), a biopharma... See more »
November 13, 2019Business WirePress Release

Verastem Oncology Announces Andrei Shustov, M.D., Recipient of 2nd Annual Innovation in Care Award

BOSTON--(BUSINESS WIRE)--Verastem, Inc. (Nasdaq: VSTM), (Verastem Oncology or the Company), a biophar... See more »
October 23, 2019centralchartsPress Release

Verastem, Inc. - VSTM Stock Chart Technical Analysis for 10-23-2019

News videos - Verastem, Inc. - VSTM Stock Chart Technical Analysis for 10-23-2019 - Published on 10/2... See more »
April 4, 2019StreetInsiderPress Release

Verastem Oncology Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Verastem, Inc.�(Nasdaq: VSTM) (Verastem Oncology or the Company), focused on developing and commercia... See more »
January 7, 2019StreetInsiderPress Release

Verastem Oncology Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Verastem, Inc.�(Nasdaq: VSTM) (Verastem Oncology or the Company), focused on developing and commercia... See more »
Loading interface...
Loading interface...
Loading interface...